Zyshak Pharmaceuticals Private Limited
About Zyshak Pharmaceuticals Private Limited
Data last updated:
Zyshak Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC288089.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹4,327. It is led by directors Seema Kulthe Dattatraya and Vijay Kumar Sharma.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at New Daulat 1 – 3 Sec – 16 A Vashi Navimumbai, Maharashtra, India – 400703.
As per the financials filed for FY 2020, the company reported a revenue of ₹2.06 Lakh, a decline of 98% compared to the previous year. For the same year it recorded a net profit of ₹49,456 (net margin 24.1%) and EBITDA of ₹49,456 (EBITDA margin 24.1%).
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Zyshak Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressNew Daulat 1 – 3 Sec – 16 A Vashi Navimumbai, Maharashtra, India – 400703
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Zyshak Pharmaceuticals Private Limited
FY 2021 filings availableZyshak Pharmaceuticals Private Limited reported revenue of ₹2.06 Lakh (down 98% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 98% in the latest year. EBITDA rose 181% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹49,456 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹49,456 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 24.1% | |||
| Net Profit Margin | 24.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Zyshak Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zyshak Pharmaceuticals Private Limited
Zyshak Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Seema Kulthe Dattatraya Also directs: Atlaseva Solutions and Projects Private Limited | Director | 01 Dec 2016 | 9 Years 10 Months | Current |
| Vijay Kumar Sharma | Director | 26 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
Zyshak Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cortex Pharmaceuticals and Medi Services Private Limited | ₹2.07 Lakh (FY 2025) | -36.0% | Surat, Gujarat, India | |||
| Bio Nucleus Pharmaceuticals Private Limited | ₹2.06 Lakh (FY 2024) | -91.0% | New Delhi, Delhi, India | |||
| Insha Pharmaceuticals Private Limited | ₹2.06 Lakh (FY 2017) | 106.0% | Uttar Pradesh, India | |||
| Remmycare Pharmaceuticals Private Limited | ₹2.06 Lakh (FY 2025) | 1683.0% | Vadodara, Gujarat, India | |||
| Pearim Pharmaceuticals Private Limited | ₹2.06 Lakh (FY 2025) | -3.0% | Mumbai, Maharashtra, India | |||
| Zyshak Pharmaceuticals Private Limitedthis company | ₹2.06 Lakh (FY 2020) | ₹49,456 | 24.1% | -98.0% | Mumbai, Maharashtra, India | |
| Hajare Lal Mitro Pharmaceuticals Private Limited | ₹2.05 Lakh (FY 2024) | Bankura, West Bengal, India | ||||
| Pipal Pharmaceuticals Private Limited | ₹2.05 Lakh (FY 2018) | -78.0% | Patna, Bihar, India | |||
| Viprans Drug and Pharmaceuticals Private Limited | ₹2.04 Lakh (FY 2022) | 121.0% | Bhopal, Madhya Pradesh, India | |||
| As Pharmaceuticals (OPC) Private Limited | ₹2.04 Lakh (FY 2021) | 0.0% | Varanasi, Uttar Pradesh, India | |||
| Pharmbrium Pharmaceuticals Private Limited | ₹2.04 Lakh (FY 2023) | 17.0% | New Delhi, Delhi, India |
To see the full peer comparison of Zyshak Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Zyshak Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zyshak Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Zyshak Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Zyshak Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Vijay Kumar Sharma was appointed as Director on 26 Sep 2020.
Frequently asked questions
Zyshak Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 December 2016 (10+ years old) and is registered under CIN U74999MH2016PTC288089.
Zyshak Pharmaceuticals has 2 current directors:
- Seema Kulthe Dattatraya - Director
- Vijay Kumar Sharma - Director
The latest financial statements of Zyshak Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Zyshak Pharmaceuticals is U74999MH2016PTC288089. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zyshak Pharmaceuticals was incorporated on 01 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Zyshak Pharmaceuticals by revenue are Cortex Pharmaceuticals and Medi Services Private Limited, Bio Nucleus Pharmaceuticals Private Limited, Insha Pharmaceuticals Private Limited, Remmycare Pharmaceuticals Private Limited, Pearim Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Vijay Kumar Sharma was appointed as Director on 26 Sep 2020. Vinay Shankar Tripathi ceased to be Director on 26 Sep 2020. Seema Kulthe Dattatraya was appointed as Director on 01 Dec 2016.
The registered office of Zyshak Pharmaceuticals is at New Daulat 1 – 3 Sec – 16 A Vashi Navimumbai, Maharashtra, India – 400703.
Zyshak Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Zyshak Pharmaceuticals is active non-compliant as of 02 August 2026. The company is actively filing with the Registrar of Companies.
Zyshak Pharmaceuticals can be reached at its registered office: New Daulat 1 – 3 Sec – 16 A Vashi Navimumbai, Maharashtra, India – 400703.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
